Search terms
Results 1 - 2 of 2 - ordered by :

In the COMPASS trial,(1,2) combined aspirin and rivaroxaban treatment reduced ischaemic events in patients with stable coronary artery disease (CAD) or peripheral artery disease (PAD). In the ...

Date : 02/10/2019

Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With ...

Date : 01/06/2019